Dr. Jeffrey Weitz discusses the implications of the EINSTEIN Choice Trial during NATF’s August 2017 online support group.
Related Articles
January 13, 2020
Clot Chronicles: Periprocedural Anticoagulation
5 Key Questions to Consider Hi, I’m Margaret Fang. I’m at the University of California, San Francisco, and I am…
December 30, 2019
Clot Chronicles: What’s New in 2020
Hello, I’m Dr. Sam Goldhaber, President of NATF, and I’m at Brigham and Women’s Hospital. And today, on Clot Chronicles, I’m…
December 15, 2019
Clot Chronicles: Building an Afib Center of Excellence
Hello, I’m Dr. Elliott Antman from the Brigham and Women’s Hospital in Boston. I’m a cardiologist here in our cardiovascular…